Dr. Ai on the Efficacy of Brentuximab Vedotin in Patients With Advanced Cutaneous T-Cell Lymphoma
6 Просмотры
• 08/09/23
0
0
встраивать
administrator
Подписчики
Weiyun Z. Ai, MD, PhD, assistant clinical professor, Department of Medicine, University of California San Francisco, discusses the scenarios in which she has seen the most benefit from brentuximab vedotin (Adcetris) in patients with advanced stage cutaneous T-cell lymphoma (CTCL).
Показать больше
Комментарии Facebook
SORT BY-
Лучшие комментарии
-
Последние комментарии